ECOG-ACRIN Staff, Author at ECOG-ACRIN Advocacy Blog

Filter by
Categories
Tags
Authors
Show all

All
Acute lymphoblastic leukemia
Acute myeloid leukemia
Adolescents and young adults
Advocacy
Anal cancer
Antioxidants
AYA
Bladder cancer
Blood cancers
Brain cancer
Breast cancer
Cancer care delivery
Caregiving
Chemotherapy
Chronic lymphocytic leukemia
Colorectal cancer
ComboMATCH
Communication
COVID-19
DCIS
DCIS breast cancer
De-escalation
Esophagus cancer
Financial hardship
Gallbladder cancer
Gastroesophageal cancer
Geriatric oncology
GI cancer
Green tea
HAI chemotherapy
Head and neck cancer
Head and neck squamous cell carcinoma
Health equity
Hepatic arterial infusion chemotherapy.
HER2+ breast cancer
Hormone therapy
Imaging
Immune system therapy
Immunotherapy
Implementation science
In memory
Kidney cancer
Language
Late Effects
Leiomyosarcoma
Leukemia
LGBTQ+
Liver cancer
Lung cancer
Lymphoma
Mammography
Mantle cell lymphoma
Melanoma
Men's health
Mesothelioma
Minimal residual disease
MRI
Multiple myeloma
Myelodysplastic syndrome
Myeloma
National Clinical Trials Network
NCI-MATCH
Neuropathy
Non-Hodgkin lymphoma
Non-small cell lung cancer
Nose and sinus cancer
Older adults
Pancreatic cancer
Pancreatic cysts
Patient advocacy
Patient care
Patient education
Patient navigation
Patient-reported outcomes
Penile cancer
Peripheral T-cell lymphoma
Personalized medicine
Personalized screening
Personalized treatment
Precision medicine
Prevention
Prostate cancer
Radiation therapy
Rare cancer
Rare cancers
Real-world data
Real-world evidence
Registry studies
Renal cell carcinoma
Research results
Sarcoma
Screening
Sexual and gender minorities
Side effects
Skin cancer
Smoldering multiple myeloma
Social genomics
Soft tissue sarcoma
Solid tumors
Squamous cell carcinoma
Surveillance
Survivorship
Symptom management
Symptom science
Targeted therapy
Throat cancer
Thyroid cancer
Trial results
Triple-negative breast cancer
Tumor test
Upper tract urothelial cancer
Urothelial cancer

July 19, 2023

Categories

Ongoing Trials

A closer look at ECOG-ACRIN’s men’s cancer trials

These trials are exploring new treatment approaches for adults with prostate or penile cancer

March 23, 2023

March 23, 2023

Categories

Editorials

Should I stay or should I go?

Many patients are unaware that stopping treatment during participation in a clinical trial does not automatically mean withdrawing from a clinical trial

March 23, 2023

March 23, 2023

Categories

Ongoing Trials

Ongoing Trials: A closer look at ECOG-ACRIN’s myeloma studies

These two trials are exploring new treatment approaches for adults with multiple myeloma

September 26, 2022

Categories

New Trials

Now Enrolling: The EA2205 research study is testing a new treatment approach for a rare form of liver cancer

Researchers at ECOG-ACRIN are studying if they can improve results for patients with liver cancer by giving chemotherapy along with drugs that help the body’s immune system fight cancer